475 related articles for article (PubMed ID: 11941272)
21. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
Commeau P; Barragan P; Roquebert PO
Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
[TBL] [Abstract][Full Text] [Related]
22. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
24. The treatment of venous leg ulcers: a new therapeutic use of iloprost.
Ferrara F; Meli F; Raimondi F; Amato C; Bonura F; Mulè G; Novo G; Novo S S
Ann Surg; 2007 Nov; 246(5):860-5. PubMed ID: 17968180
[TBL] [Abstract][Full Text] [Related]
25. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol.
Milio G; Corrado E; Genova C; Amato C; Raimondi F; Almasio PL; Novo S
Rheumatology (Oxford); 2006 Aug; 45(8):999-1004. PubMed ID: 16484290
[TBL] [Abstract][Full Text] [Related]
26. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
[TBL] [Abstract][Full Text] [Related]
28. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
29. [The role of iloprost in the treatment of critical ischemia of the limbs].
Poggesi L; Comeglio M
Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous transluminal angioplasty for critical limb ischaemia in octogenarians and nonagenarians.
Salas CA; Adam DJ; Papavassiliou VG; London NJ
Eur J Vasc Endovasc Surg; 2004 Aug; 28(2):142-5. PubMed ID: 15234694
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of low-dose intravenous enoxaparin and GP IIb/IIIa inhibitor therapy during PCI.
Carnendran L; Borkowski R; Markabawi B; Warner MF
J Invasive Cardiol; 2003 May; 15(5):235-8. PubMed ID: 12730628
[TBL] [Abstract][Full Text] [Related]
32. Iloprost as cyclic five-day infusions in the treatment of scleroderma. An open pilot study in 20 patients treated for one year.
Biasi D; Carletto A; Caramaschi P; Zeminian S; Pacor ML; Corrocher R; Bambara LM
Rev Rhum Engl Ed; 1998 Dec; 65(12):745-50. PubMed ID: 9923042
[TBL] [Abstract][Full Text] [Related]
33. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
34. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
[TBL] [Abstract][Full Text] [Related]
35. Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
Haab F; Cardozo L; Chapple C; Ridder AM;
Eur Urol; 2005 Mar; 47(3):376-84. PubMed ID: 15716204
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
37. Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo clinic experience, 2004-2006.
Kavros SJ; Miller JL; Hanna SW
Adv Skin Wound Care; 2007 Apr; 20(4):221-6. PubMed ID: 17415030
[TBL] [Abstract][Full Text] [Related]
38. [Behavior of endothelin plasma levels during iloprost infusion in patients with severe ischemia in the lower extremities].
Battistelli S; Borgogni T; Gori S; Manasse G
Minerva Cardioangiol; 1995 Jun; 43(6):257-62. PubMed ID: 7566538
[TBL] [Abstract][Full Text] [Related]
39. Subintimal angioplasty of infrapopliteal artery occlusions in the treatment of critical limb ischaemia. Short-term results.
Tartari S; Zattoni L; Rolma G; Sacco A
Radiol Med; 2004 Sep; 108(3):265-74. PubMed ID: 15343140
[TBL] [Abstract][Full Text] [Related]
40. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
